Comar obtains CE certification for medical devices in accordance with the new EU MDR regulations

BUENA, New Jersey,

May 29, 2024

/PRNewswire/ — COMAR, a leading provider of innovative medical devices and packaging solutions, is pleased to announce a significant achievement. After rigorous preparations, they have successfully obtained CE certification under the latest EU regulations for medical devices (EU MDR 2017/745).

This certificate is a significant milestone and confirms COMAR’s compliance with the latest European Union standards for medical devices. The new EU MDR regulation introduces more stringent requirements for the safety and performance of medical devices, aiming to ensure patient safety and device traceability. Successful certification demonstrates COMAR’s commitment to excellence and bringing to market high-impact solutions that can positively impact the world around us.

Thanks to this certification, COMAR can continue to sell CE marked oral/topical devices in the European Union, in particular Class I devices with a measuring function and Class I non-measuring devices that are push-in bottle adapters. The certification covers COMAR oral syringes, dosing cups (AccuCup®), dosing spoons, measuring cups and dropper assemblies.

“Receiving the new CE certification under the EU MDR is a testament to the dedication and hard work of our entire team,” he said

Sonia Hardikar

, vice president for quality and regulations at COMAR. “This achievement reflects our unwavering commitment to providing our customers with safe and reliable medical devices. We are excited to continue serving our European customers while exploring new opportunities with this certification.”

COMAR would like to thank everyone involved in this important milestone. We sincerely appreciate the dedication and hard work of our entire team, the support of our valued clients and the cooperation with the certification body and auditors. This achievement sets the stage for further development and innovation in the medical device and pharmaceutical sectors.

Experience progress that never stops. Meet Comar.

Comar based in

Voorhees, New Jersey

, has 11 strategic manufacturing and distribution locations and utilizes a range of plastics molding technologies, including injection molding, injection blow molding, injection stretch blow molding and extrusion blow molding, which are complemented by a full suite of value-added services. For 75 years, Comar has been working with customers to bring effective packaging and medical solutions to market, transforming them from concept to reality, where they can positively impact the world around us. The majority shareholder of Comar is Morgan Stanley Capital Partners.

View original content to download multimedia: https://www.prnewswire.com/news-releases/comar-achieves-ce-certification-for-medical-devices-under-new-eu-mdr-regulations-302158296.html

SOURCE Comar